|1.||Hammock, Bruce D: 3 articles (12/2014 - 03/2011)|
|2.||Zheng, Y P: 3 articles (05/2012 - 06/2005)|
|3.||El-Kadi, Ayman O S: 2 articles (04/2013 - 03/2011)|
|4.||Zordoky, Beshay N M: 2 articles (04/2013 - 03/2011)|
|5.||Li-Tsang, Cecilia W P: 2 articles (08/2005 - 06/2005)|
|6.||Lau, Joy C M: 2 articles (08/2005 - 06/2005)|
|7.||Lein, Pamela J: 1 article (12/2014)|
|8.||Vito, Stephen T: 1 article (12/2014)|
|9.||Tancredi, Daniel J: 1 article (12/2014)|
|10.||Inceoglu, Bora: 1 article (12/2014)|
|1.||Body Weight (Weight, Body)
05/01/2012 - "In this study, a foot scanner incorporating a tissue ultrasound palpation (indentation) system (TUPS) which could assess the mechanical properties of plantar soft tissues under different body-weight loading was developed. "
04/01/2013 - "Isoprenaline significantly induced the hypertrophic, fibrotic markers as well as the heart to body weight ratio, which was significantly reversed by TUPS. "
03/01/2011 - "Treatment with TUPS significantly reversed the BaP-mediated induction of the hypertrophic markers, completely prevented the increase in the heart to body weight ratio, and reduced the BaP-induced CYP1A1, CYP1B1, CYP4F4, and CYP4F5 genes in the heart. "
|2.||Cardiomegaly (Heart Hypertrophy)
03/01/2011 - "The current study demonstrates the cardioprotective effect of sEH inhibitor, TUPS, against BaP-induced cardiac hypertrophy and further confirms the role of sEH and CYP450 enzymes in the development of cardiac hypertrophy."
04/01/2013 - "Therefore, it is important to examine whether the inhibition of sEH by 1-(1-methanesulfonyl-piperidin-4-yl)-3-(4-trifluoromethoxy-phenyl)-urea (TUPS) will protect against isoprenaline-induced cardiac hypertrophy. "
04/01/2013 - "TUPS partially protects against isoprenaline-induced cardiac hypertrophy, which confirms the role of sEH and CYP enzymes in the development of cardiac hypertrophy."
04/01/2013 - "Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy."
06/01/2005 - "In this study, we have adopted a newly developed and user-friendly Tissue ultrasound palpation system (TUPS) for the assessment of scar thickness. "
08/01/2005 - "The tissue ultrasound palpation system (TUPS) was employed to measure scar thickness. "
06/01/2005 - "TUPS was proved to have high inter-rater, test-retest reliability and it had a moderate correlation with the VSS that clinicians used for assessment of the scar. "
06/01/2005 - "They were assessed using TUPS as well as the Vancouver Scar Scale (VSS) for rating scar thickness, pliability, pigmentation and vascularity. "
06/01/2005 - "Application of tissue ultrasound palpation system (TUPS) in objective scar evaluation."
|4.||Hypertrophic Cicatrix (Hypertrophic Scar)
|5.||Spinal Cord Injuries (Spinal Cord Injury)
|2.||Cytochrome P-450 CYP1A1 (CYP1A1)
|5.||cytochrome P-450 CYP1B1 (CYP1B1)